laitimes

Announcement Highlights: PetroChina's 2021 net profit pre-increase of 374%-395%; Jiuan Medical's US subsidiary signed an order for new crown antigen home self-test OTC kits

author:Securities Times E Company

【Operating Data】

PetroChina: 2021 net profit pre-increase 374%-395% year-on-year

PetroChina (601857) disclosed its performance forecast on the evening of January 12, and it expects net profit to increase by 71 billion yuan to 75 billion yuan in 2021, an increase of 374% to 395% year-on-year. The sales of the company's main oil and gas products have increased in volume and efficiency.

Hebang Bio: Net profit in 2021 pre-increased by 7227.36%-7960.09% year-on-year

Hebang Bio (603077) disclosed its performance forecast on the evening of January 12, and it is expected that the net profit in 2021 will increase by 2.96 billion yuan to 3.26 billion yuan, an increase of 7227.36% - 7960.09% year-on-year. During the reporting period, the company's main products are bisphosate, glyphosate, soda ash, ammonium chloride, glass, benefiting from the improvement of environmental protection requirements and the further clearance of backward production capacity caused by the epidemic, the expansion of production capacity is restricted, and the growth of downstream demand is superimposed, thereby driving sales prices to rise.

CITIC Securities Performance Express: 2021 Net Profit Increased by 54.2% Year-on-Year

CITIC Securities (600030) disclosed its performance report on the evening of January 12, achieving operating income of 76.570 billion yuan in 2021, an increase of 40.80% year-on-year; and achieving a net profit of 22.979 billion yuan, an increase of 54.2% year-on-year.

Huayi Group: 2021 net profit pre-increase of 561%-656% year-on-year

Huayi Group (600623) disclosed its performance forecast on the evening of January 12, and it is expected that the net profit in 2021 will increase by 2.377 billion yuan to 2.777 billion yuan year-on-year, an increase of 561% to 656% year-on-year. Mainly due to the company's better downstream demand for chemical products in 2021, the market price of major products increased significantly year-on-year.

Sanfu shares: 2021 net profit pre-increase of 235% -254% year-on-year

Sanfu Co., Ltd. (603938) disclosed its performance forecast on the evening of January 12, and it is expected that the net profit in 2021 will be 3.326 billion yuan - 345 million yuan, an increase of 234.85% - 254.36% year-on-year. The company's main products trichlorosilane, high-purity silicon tetrachloride, potassium hydroxide, potassium sulfate sales prices have increased compared with 2020, of which trichlorosilane is driven by the growth of downstream market demand, the price has increased significantly year-on-year. In addition, the company intends to invest 100 million yuan to establish a wholly-owned subsidiary, Sanfu (Tianjin) Chemical Technology Co., Ltd.

Hands-on CNC: 2021 net profit pre-increase of 207%-239% year-on-year

On the evening of January 12, the company's cnc (603185) disclosed its performance forecast, and it is expected that the company's net profit in 2021 will be 1.63 billion yuan to 1.8 billion yuan, an increase of 207% to 239% year-on-year. In 2021, the company expanded the scale of monocrystalline silicon business as planned, and the production capacity continued to increase, maintaining a good capacity utilization rate and production and marketing rate. The sales scale of the company's monocrystalline silicon business continued to expand, which made the company's sales revenue grow and promoted the company's performance to rise steadily.

Shandong glass fiber: 2021 net profit pre-increase 195% to 246% year-on-year

Shandong Glass Fiber (605006) disclosed its performance forecast on the evening of January 12, and it is expected that the net profit in 2021 will be 509 million yuan to 597 million yuan, an increase of 195.11% to 246.43% year-on-year. With the country's control of the epidemic, the impact of the epidemic has been weakening, the demand for glass fiber downstream applications is strong, the export of foreign trade has increased significantly, and the sales volume and price of glass fiber yarn have risen together.

Yahua Group: Net profit in 2021 pre-increase of 184.09%-224.23% year-on-year

Yahua Group (002497) announced on the evening of January 12 that the company's pre-profit in 2021 was 920 million yuan - 1.05 billion yuan, an increase of 184.09% - 224.23% year-on-year. During the reporting period, the company's two main industries of civil explosion and lithium industry continued to exert force, the civil explosion business developed steadily, and the demand for lithium industry continued to rise; the company seized the new energy industry cycle, released production capacity, increased sales, significantly increased the sales volume of lithium salt products, greatly increased the profit of lithium business, and significantly improved the overall profitability of the company.

Teyi Pharmaceutical: Net profit in 2021 pre-increased by 173.87%-242.34% year-on-year

Teyi Pharmaceutical (002728) released a performance forecast on the evening of January 12, and it is expected that the net profit attributable to the mother in 2021 will be 120 million yuan to 150 million yuan, an increase of 173.87% to 242.34% year-on-year. During the reporting period, the company's business basically returned to normal levels, and sales revenue, especially the sales of the core product "special one" brand cough tablets, recovered well; at the same time, the company continued to strengthen brand building, optimize product structure, increase internal management, adhere to cost reduction and efficiency increase, and achieved good results during the reporting period.

Snow salt industry: 2021 net profit pre-increase of 161% -196% year-on-year

Snow Sky Salt (600929) disclosed its performance forecast on the evening of January 12, and it is expected that the net profit in 2021 will increase by 230 million yuan to 280 million yuan, an increase of 161% to 196% year-on-year. The pre-increase in performance is mainly due to the completion of the acquisition of 100% of the equity of Chongqing Xiangyu Salinization Co., Ltd. under the same control in 2021, which was included in the consolidated statement, and the net profit increased by about 206 million yuan.

Tiannai Technology: 2021 net profit pre-increase of 166% -184% year-on-year

Tiannai Technology (688116) disclosed its performance forecast on the evening of January 12, and it is expected that the net profit in 2021 will be 285 million yuan - 305 million yuan, an increase of 165.73% to 184.38% year-on-year. During the reporting period, due to the rapid development of the downstream new energy automobile industry, the demand for carbon nanotube conductive paste products in the fields of power lithium batteries increased rapidly, and the sales volume of the company's main product carbon nanotube conductive paste increased, and the sales revenue increased significantly compared with the same period last year; the downstream power battery enterprises' demand for carbon nanotube conductive paste substitution increased, prompting the company's main product carbon nanotube conductive paste demand growth.

Sanyou Chemical: Net profit in 2021 pre-increased by about 134% year-on-year

Sanyou Chemical (600409) disclosed its performance forecast on the evening of January 12, and it is expected that the net profit in 2021 will increase by about 960 million yuan, an increase of about 134% year-on-year. During the reporting period, the price of the company's leading products viscose staple fiber, soda ash, caustic soda, and dimethicone hybrid ring body increased significantly year-on-year.

Lubei Chemical: Net profit in 2021 is expected to increase by about 117% year-on-year

Lubei Chemical (600727) disclosed its performance forecast on the evening of January 12, and it is expected that the net profit in 2021 will increase by about 270 million yuan, an increase of about 117% year-on-year. This was mainly due to the significant increase in revenue due to the year-on-year increase in the sales price of the main products.

Yinbang shares: 2021 net profit pre-increase of 106.33% -165.28% year-on-year

Yinbang Shares (300337) released a performance forecast on the evening of January 12, and it is expected that the net profit attributable to the mother in 2021 will be 35 million yuan - 45 million yuan, an increase of 106.33% - 165.28% year-on-year. During the reporting period, benefiting from the strong market demand in the downstream industry, the company's output and sales volume have increased significantly compared with the previous year, especially under the in-depth promotion of the national "carbon peak, carbon neutrality" strategy, new energy vehicles showed an explosive growth momentum, the company's production of cooling power battery thermal management aluminum heat transmission materials and other products in the client rapid volume and continuous penetration, business steady development.

Chujiang New Material: Net profit in 2021 pre-increased by 100.55%-118.78% year-on-year

Chujiang New Materials (002171) released a performance forecast on the evening of January 12, and it is expected that the net profit attributable to the mother in 2021 will be 550 million yuan - 600 million yuan, an increase of 100.55% - 118.78% year-on-year. Copper-based material plate and strip product upgrade, capacity replacement and intelligent transformation project reached production, the business scale increased, the product structure was optimized, and the added value of the product was improved. The downstream demand of the military carbon materials and its special equipment business sector is strong, and the first phase of the aircraft carbon brake precast capacity expansion construction project and the carbon fiber thermal field precast industrialization project was completed and put into operation, with production capacity improvement and performance growth.

Chiyu shares: 2021 net profit pre-increase of about 89.47% year-on-year

Chiyou (603429) disclosed its performance forecast on the evening of January 12, and it is expected that the company's net profit in 2021 will be about 136 million yuan, an increase of about 89.47% year-on-year.

Jingsheng Electromechanical: Net profit in 2021 pre-increased by 84.11%-114.41% year-on-year

Jingsheng Electromechanical (300316) released a performance forecast on the evening of January 12, and it is expected that the net profit attributable to the mother in 2021 will be 1.580 billion yuan - 1.840 billion yuan, an increase of 84.11% - 114.41% year-on-year. During the reporting period, benefiting from the active promotion of production expansion progress by downstream silicon wafer manufacturers in the photovoltaic industry, the company achieved a substantial increase in order volume, operating income scale and operating performance year-on-year. At the same time, the localization process of domestic semiconductor equipment has accelerated, the company's semiconductor equipment orders have increased year-on-year, and the company's sapphire material business and auxiliary consumables business have also achieved rapid development, which has made positive contributions to the growth of the company's operating performance.

Espressif Systems: 2021 net profit pre-increase of 83%-102% year-on-year

Espressif Systems (688018) disclosed its performance forecast on the evening of January 12, and it expects its net profit in 2021 to be 190 million yuan to 210 million yuan, an increase of 83% to 102% year-on-year. The overall shipment volume of all products increased by 30%-40% year-on-year.

Huajian Group: 2021 net profit pre-increase of 75%-95% year-on-year

Huajian Group (600629) disclosed its performance forecast on the evening of January 12, and it expects its net profit to increase by 130 million yuan to 165 million yuan in 2021, an increase of 75% to 95% year-on-year.

Tuopu Group: 2021 net profit pre-increase of 67-83% year-on-year

Tuopu Group (601689) disclosed its performance forecast on the evening of January 12, and it is expected that the net profit in 2021 will be 1.05 billion yuan to 1.15 billion yuan, an increase of 67-83% year-on-year. During the reporting period, thanks to the company's forward-looking grasp of the market opportunities in the new energy automobile industry, the continuous expansion of intelligent electric related product lines, the active expansion of the international and domestic intelligent electric customer base, relying on system research and development and modular supply and other capabilities to innovate business models, the amount of bicycle supply has increased significantly, and the company's new energy vehicle business has grown rapidly.

Zhongxing mushroom industry: net profit in 2021 pre-decreased by 66.66%-77.24% year-on-year

Zhongxing Mushroom Industry (002772) released a performance forecast on the evening of January 12, and it is expected that the net profit attributable to the mother in 2021 will be 43 million yuan - 63 million yuan, down 66.66% - 77.24% year-on-year. Affected by the trade in bulk goods, the overall purchase price of raw materials for the production of edible mushrooms has risen, and the cost of products has increased significantly; in the post-epidemic era, the consumption of edible mushrooms in the downstream market is weak, especially the sales price of enoki mushroom products continues to be sluggish, and the market performance in the traditional peak sales season is poor; the repeated epidemic situation, heavy rain disasters and other factors have led to the scrapping of some batches of finished products and products.

Xinjiang Communications Construction: Net profit in 2021 pre-increase of 61.34%-141.58% year-on-year

Xinjiang Communications Construction (002941) released a performance forecast on the evening of January 12, and it is expected that the net profit attributable to the mother in 2021 will be 185 million yuan - 277 million yuan, an increase of 61.34% - 141.58% year-on-year. In 2021, key projects such as the Minluo Project, the Jing'a Project, the S21 Awu Project, and the Jiangao Railway Project were large in scale, and the revenue and net profit increased more than the same period last year; the outbreak of the epidemic in 2020 had a certain impact on the company's bulk material procurement, logistics, personnel flow and business expansion, resulting in an increase in costs, and the company's operation in 2021 was less affected by the epidemic than the previous year.

Sail cable: 2021 net profit pre-increase of 58.78%-72.68% year-on-year

Sail Cable (605222) disclosed its performance forecast on the evening of January 12, and the company expects its net profit in 2021 to be 651 million yuan - 708 million yuan, an increase of 58.78% - 72.68% year-on-year. During the reporting period, the company's production and marketing scale increased steadily, and its operation continued to improve.

Xiamen Xiangyu: 2021 net profit pre-increase of 51%-70% year-on-year

Xiamen Xiangyu (600057) disclosed its performance forecast on the evening of January 12, and the company expects its net profit in 2021 to be 1.960 billion yuan to 2.210 billion yuan, an increase of 660 million yuan to 910 million yuan over the same period of the previous year, an increase of 51% to 70% year-on-year.

Tigermed: 2021 net profit pre-increase of 50%-73% year-on-year

Tigermed (300347) released a performance forecast on the evening of January 12, and it is expected that the net profit attributable to the mother in 2021 will be 2.625 billion yuan - 3.027 billion yuan, an increase of 50% - 73% year-on-year. During the reporting period, the company's main business continued to grow. Non-recurring profit and loss of 1.4 billion yuan to 1.8 billion yuan in 2021, mainly due to the fair value change gains of financial assets recognized by the company in accordance with the new financial instrument standards and the income from equity transfer, and the financial assets invested by the company are mainly biomedicine, medical devices and other companies related to the company's main business, as well as medical and health professional investment funds.

Haichen shares: 2021 net profit pre-increase of 50% -70% year-on-year

Haichen Co., Ltd. (300873) released a performance forecast on the evening of January 12, and it is expected that the net profit attributable to the mother in 2021 will be 292 million yuan to 331 million yuan, an increase of 50% to 70% year-on-year. In 2021, the IT electronics industry and the new energy automobile industry produced and sold both booming, the scope of cooperation between the company and major customers expanded, and the expansion of new customers was smooth, resulting in the growth of operating income. In 2021, the company's new generation of transportation management system (Shenzhang system) was successfully launched, making a significant contribution to profit growth.

Baofeng Energy: 2021 net profit pre-increase of 47%-56% year-on-year

Baofeng Energy (600989) disclosed its performance forecast on the evening of January 12, and it is expected to achieve a net profit of 6.8 billion yuan to 7.2 billion yuan in 2021, an increase of 47.10% to 55.75% year-on-year. The performance pre-increase is mainly due to the continuous improvement of the company's industrial chain, and the advantages of industrial chain integration are more obvious, which effectively alleviates the impact of the sharp rise in raw material prices; at the same time, the price of the company's main products in 2021 has increased significantly year-on-year.

Youboxun: 2021 net profit pre-increase of 34.25% -67.81% year-on-year

Youboxun (300531) released a performance forecast on the evening of January 12, and it is expected that the net profit attributable to the mother in 2021 will be 160 million yuan - 200 million yuan, an increase of 34.25% - 67.81% year-on-year. In 2021, the company's overseas market business gradually recovered, combined with the company's advantageous layout in supply chain management, with good product performance, sufficient and stable supply delivery capabilities and other advantages, domestic and foreign sales revenue achieved rapid growth compared with the same period last year.

Sully share performance report: 2021 net profit increased by 29.58% year-on-year

Suli Shares (603585) disclosed on the evening of January 12 that the company achieved a total operating income of 2.284 billion yuan in 2021, an increase of 46.54% year-on-year; achieved a net profit of 226 million yuan, an increase of 29.58% year-on-year.

Bank of Qingdao Performance Express: Net profit in 2021 was 2.923 billion yuan, an increase of 22.08% year-on-year

Bank of Qingdao (002948) released a performance report on the evening of January 12, with operating income of 11.136 billion yuan in 2021, an increase of 5.65% year-on-year; net profit attributable to the mother of 2.923 billion yuan, an increase of 22.08% year-on-year; and basic earnings per share of 0.54 yuan.

Tailin Bio: 2021 annual net profit pre-increase of 20.02%-50% year-on-year

Tailin Biological (300813) disclosed the performance forecast on the evening of January 12, and the company expects a net profit of 58.07 million yuan to 72.58 million yuan in 2021, an increase of 20.02% to 50% year-on-year.

Bluebird Fire: Net profit in 2021 pre-increased by 12.78%-29.06% year-on-year

BlueBird Fire (002960) released a performance forecast on the evening of January 12, and it is expected that the net profit attributable to the mother in 2021 will be 485 million yuan - 555 million yuan, an increase of 12.78% - 29.06% year-on-year. The company's 2021 product orders, shipments, payment collection indicators grew rapidly year-on-year, and it is expected to achieve operating income of 3.7 billion yuan to 4.2 billion yuan, an increase of 46.56% to 66.36% over the same period of the previous year.

AVIC: Net profit in 2021 pre-increase of 10%-30% year-on-year

China Aviation Electronics (300114) announced on the evening of January 12 that the company's pre-profit in 2021 was 289 million yuan - 341 million yuan, an increase of 10% -30% year-on-year. During the reporting period, although the motor vehicle testing business declined significantly due to changes in industry policies, the aviation military business and the sensing control business seized the opportunities of industry and market development and achieved rapid growth, especially the sensor control subdivision businesses such as consumer electronics and smart logistics continued to maintain a rapid development trend, which promoted the steady growth of the company's operating performance.

Stellar Technology: 2021 net profit pre-increase of 6.29%-38.18% year-on-year

Stellar Technology (002132) released a performance forecast on the evening of January 12, and it is expected that the net profit attributable to the mother in 2021 will be 13,000 yuan - 16,900 yuan, an increase of 6.29% - 38.18% year-on-year. In 2021, although affected by the epidemic, natural disasters, fluctuations in raw material prices and employee stock ownership plan expenses, the company's main business product revenue growth was stable, especially the production and sales of diamond wire products increased significantly compared with the same period last year, bringing a strong profit growth point to the company, thereby driving the company's overall profit increase.

Suken Nongfa Performance Express: Net profit in 2021 increased by 9.47% year-on-year

Suken Nongfa (601952) disclosed on the evening of January 11 that the company achieved a net profit of 733 million yuan in 2021, an increase of 9.47% year-on-year.

Sunshine Guojian: It is expected that the net profit in 2021 will be 18 million yuan - 22 million yuan to achieve a turnaround

Sunshine Guojian (688336) disclosed its performance forecast on the evening of January 12, and it is expected that the net profit in 2021 will be 18 million yuan to 22 million yuan, achieving a year-on-year turnaround. Since the price reduction of the company's main product, Yisaipu, sales have increased significantly, and sales revenue has increased accordingly.

Sanju Environmental Protection: 2021 pre-profit of 69 million yuan - 103 million yuan year-on-year turnaround

Sanju Environmental Protection (300072) released a performance forecast on the evening of January 12, and it is expected that the net profit attributable to the mother in 2021 will be 69 million yuan - 103 million yuan, a year-on-year turnaround. During the reporting period, through its long-term technical accumulation and practice in the fields of suspended beds, fixed beds, catalysts, etc., the company promoted the industrialization and application of bioenergy, promoted the construction of the company's core operating asset system, and achieved the sustainable and stable development of the company.

Keshun shares: 2021 net profit pre-year-on-year decline of 29.24% -10.15%

Keshun Co., Ltd. (300737) released a performance forecast on the evening of January 12, and it is expected that the net profit attributable to the mother in 2021 will be 630 million yuan to 800 million yuan, down 29.24% to 10.15% year-on-year. In 2021, the company's shipments maintained steady growth, but the price of upstream raw materials such as asphalt and emulsion rose sharply, resulting in a corresponding increase in the company's production costs, a decline in sales gross profit margin, and a provision for bad debts in accounts receivable.

Petty shares: net profit in 2021 pre-decreased by 21.62% - 47.75% year-on-year

Petty Shares (300673) announced on the evening of January 12 that the company's 2021 pre-profit was 60 million yuan – 90 million yuan, down 21.62% - 47.75% year-on-year. Due to the impact of the epidemic, the Vietnam plant has temporarily suspended work since early August 2021 and resumed production in late October 2021. The Vietnam plant is the company's main source of revenue and profit, and the shutdown has an impact on the company's revenue and profit in the third and fourth quarters. After the suspension of work and production, the company's costs and expenses such as manufacturing expenses and management expenses in the fourth quarter were increased, which also had a certain impact on the company's 2021 annual results.

Evergreen Group: 2021 pre-loss of 155 million yuan – 180 million yuan year-on-year loss

Evergreen Group (002616) announced on the evening of January 12 that the company's pre-loss in 2021 was 155 million yuan – 180 million yuan, a year-on-year loss. The project of Guangdong Changqing (Group) Xiongxian Thermal Power Co., Ltd. is no longer in line with the comprehensive energy model planned in Xiong'an New Area. After several rounds of research and demonstration, the company decided to terminate the implementation of the project. The Company intends to record a significant asset impairment loss on the project in the fourth quarter of 2021. During the reporting period, coal prices rose sharply, much higher than in previous years. The cost of biomass fuels has risen due to rising energy prices and abnormal weather.

Chinese insurance: The original insurance premium income in 2021 totaled 581.047 billion yuan

Chinese Insurance (601319) announced on the evening of January 12 that the original insurance premium income obtained in 2021 through the company's subsidiaries Chinese Min Property & Casualty Insurance Co., Ltd., Chinese Life Insurance Co., Ltd. and Chinese Min Life Insurance Co., Ltd. was 448.384 billion yuan, 96.847 billion yuan and 35.816 billion yuan respectively.

Ningbo Port: Cargo throughput of 945.27 million tons in 2021 is expected to increase by 2.9% year-on-year

Ningbo Port (601018) announced on the evening of January 12 that in December 2021, the company expects to complete container throughput of 2.42 million TEUs, down 4.4% year-on-year; it is expected to complete cargo throughput of 71.24 million tons, an increase of 3.9% year-on-year. In 2021, the company is expected to complete a container throughput of 34.3 million TEUs for the whole year, an increase of 8.1% year-on-year; and it is expected to complete the cargo throughput of 945.27 million tons, an increase of 2.9% year-on-year.

Yaxing Bus: Sales of 339 units in December 2021, down 33% year-on-year

Yaxing Bus (600213) released the December 2021 production and sales data express report on the evening of January 12, with a production volume of 333 vehicles, down 33% year-on-year; sales of 339 vehicles, down 33% year-on-year. From January to December 2021, the cumulative production volume was 1971 units, down 35% year-on-year; the cumulative sales volume was 2023 units, down 33% year-on-year.

Panjiang shares: coal sales revenue in the fourth quarter of 2021 increased by 113% year-on-year

Panjiang Co., Ltd. (600395) released the main business data for the fourth quarter of 2021 on the evening of January 12, with coal production of 2.987 million tons, an increase of 17.91% year-on-year; coal sales of 3.1457 million tons, an increase of 18.46% year-on-year, of which 2.8772 million tons of self-produced coal sales, an increase of 13.83%. Coal sales revenue was 3.433 billion yuan, an increase of 113.36% year-on-year, and gross profit was 1.14 billion yuan, an increase of 129.79% year-on-year.

【Hot Spots】

Jiuan Medical: The US subsidiary signed an order for OTC kits for home self-testing of new crown antigens

Jiuan Medical (002432) announced on the evening of January 12 that the following orders for iHealth new crown antigen home self-test OTC kits sent from New York Anderson from New York and Massachusetts by the company's US subsidiary were effective on the day of receipt of the order (local time). The new York state order amounted to $65.31 million (including freight), about 416 million yuan, and the Massachusetts order amounted to $148 million (including freight), or about 944 million yuan. In addition, the contract for the sale of iHealth kits signed with the New York State Department of Health in the United States came into effect on January 10, local time, and the total amount of contract price and tax was 120 million US dollars (including freight), which was about 764 million yuan.

Heatscape Biology: There is a risk of fierce market competition in the sales of new crown antigen detection reagent products

Heatscape Biological (688068) issued an announcement on abnormal fluctuations in stock trading on the evening of January 12, and the company's new crown antigen detection reagent obtained the registration / filing of major economies such as the EU CE is not exclusive to the company, and there are many similar or similar competitive products in the market, and there is a risk of fierce market competition in the sales of the company's products.

Botuo Bio: The new crown self-test agent products face fierce market competition risks Sales and profit contributions are uncertain

On the evening of January 12, Botuo Bio (688767) issued an announcement of abnormal fluctuations in stock trading, and the company's new coronavirus antigen self-testing agent products have a number of similar products or other testing products in the European and Australian markets, and the company's products will face fierce market competition risks. Affected by the development of the overseas epidemic and epidemic prevention and control policies, market competition, the path selection of international epidemics on technical products, the company's product competitiveness and channel capabilities, and the degree of customer recognition, the sales and profit contribution of the above-mentioned new crown products are uncertain.

【M&A and Restructuring】

CSSC Technology: Plans to issue shares to purchase assets and raise supporting funds Resumption of trading on the 13th

CSSC Technology (600072) announced on the evening of January 12 that the company intends to issue RMB ordinary shares to the counterparty to purchase 100% of the shares of China Haijia, 10% of the equity of Lingjiu Electric, 44.64% of the equity of Luoyang Shuangrui, 88.58% of the equity of CSSC Wind Power and 100% of the equity of Xinjiang Hai, and intends to raise supporting funds from the non-public issuance of shares to no more than 35 qualified specific investors, and the company's shares will resume trading from the opening of the market on January 13.

Anel: Proposed acquisition of a 20% stake in Red Vision

Anair (002875) announced on the evening of January 12 that Anair Design Company, a wholly-owned subsidiary of the company, intends to acquire 20% of the equity of Shenzhen Red Vision Cultural Communication Co., Ltd., a short video platform IP and brand agency operating enterprise held by Changsha Kangzhuo Garment Partnership (Limited Partnership) for 80 million yuan in cash. The company will use the experience and resources of Red Motion Vision to help the company conduct live sales on platforms such as Douyin and Kuaishou to enhance the company's profitability.

Ewell Lithium Energy: will directly hold a 49% stake in Schmidt Lithium

Yiwei Lithium Energy (300014) announced on the evening of January 12 that recently, the company successfully auctioned 35.2857% of the equity of Xinghua Lithium Salt held by Chai Jiantou, and the final transaction price was 144 million yuan (excluding auction service fees). At the same time, with reference to the company's above-mentioned auction transaction amount, the company transferred 13.7143% of the equity of Xinghua lithium salt held by Zhai Yanhong for 56.015848 million yuan. After the completion of the above transaction, the company will directly hold 49% of the equity of Schmidt Lithium Salt, which is conducive to the company's further focus on the main business of lithium batteries.

【Refinancing】

Baosteel shares: The public issuance of corporate bonds of not more than 20 billion yuan was approved by the CSRC

Baosteel (600019) announced on the evening of January 12 that the CSRC approved the company's public offering of corporate bonds with a total face value of no more than 20 billion yuan to professional investors.

Ecodi: It is planned to issue convertible bonds to raise no more than 1.6 billion yuan for the intelligent manufacturing technology industrial park project

On the evening of January 12, Ikodi (600933) announced that the company intends to publicly issue convertible corporate bonds to raise no more than 1.6 billion yuan, which will be used for the Aikodi Intelligent Manufacturing Technology Industrial Park project after deducting the issuance fee.

Fu Rong Technology: It is planned to issue convertible bonds to raise no more than 640 million yuan for projects with an annual output of 100,000 tons of recycled aluminum

Fu Rong Technology (603327) announced on the evening of January 12 that the company intends to issue convertible bonds to raise no more than 640 million yuan, and the net amount after deducting the issuance fee will be used for "60,000 tons of consumer electronics aluminum profile and deep processing project" and "annual output of 100,000 tons of recycled aluminum and round casting ingot project". In addition, the company intends to build a high-end manufacturing base project for high-precision electronic consumption and new materials in Luoyuan County, Fuzhou City, Fujian Province, and plans to purchase 942.3 mu of land at one time, with an investment amount of 5 billion yuan. After the project is fully completed, the company will add new consumer electronics aluminum production capacity, which will help the company solve the problem of insufficient production capacity in the peak season.

Titan shares: It is proposed to issue convertible bonds of not more than 295.5 million yuan for the construction of intelligent textile machinery equipment manufacturing base

Titan Co., Ltd. (003036) announced on the evening of January 12 that it intends to publicly issue convertible corporate bonds with a total amount of not more than 295.5 million yuan for the construction of intelligent textile machinery and equipment manufacturing base, the construction project of Hangzhou R&D center and supplementary working capital.

【Change of Equity】

Dr. Peng: The controlling shareholder intends to transfer 10.58% of its shares to Yun Yihui

Dr. Peng announced (600804) on the evening of January 12 that the controlling shareholder, Xin pengyun, intends to transfer its 10.58% share agreement to Yun Yihui for a total transfer price of 1.09 billion yuan. Although the change in equity led to the change of the direct controlling shareholder of the company from Xinpengyun to Yun Yihui, the actual controller did not change.

Zhongfutong: The actual controller intends to transfer 7.04% of the shares to Jinan Tiefu

On the evening of January 12, Zhongfutong (300560) announced that Mr. Chen Rongjie, the controlling shareholder and actual controller of the Company, intends to transfer 15.9363 million shares of the company's unlimited sale and circulation shares held by him to Jinan Tiefu Investment Partnership (Limited Partnership) (hereinafter referred to as "Jinan Tiefu") by way of agreement transfer, accounting for 7.04% of the total share capital of the company, with a total share transfer price of 200 million yuan.

Zhenhai shares: Zhao Liwei and 40 other natural persons intend to transfer 5.04% of the company's shares held by them to Shuntong Group

Zhenhai Shares (603637) announced on the evening of January 12 that 40 natural persons, including Zhao Liwei, Fan Qihai, Fan Xiaomei and Weng Wei, intend to transfer 5.04% of the company's shares they hold to Shuntong Group at a transfer price of 14.28 yuan per share and a total transfer price of 175 million yuan. At the same time, Shuntong Group, Shunjian Group, Zhao Liwei, Fan Qihai, Fan Xiaomei and Weng Wei signed the "Concerted Action Agreement". After the completion of this share transfer, Shuntong Group will hold 16.53% of the company's shares, becoming the company's largest shareholder.

【Increase or decrease】

Aier Ophthalmology: The vice chairman intends to increase his shareholding in the company by not less than 5 million shares

Aier Ophthalmology (300015) announced on the evening of January 12 that on January 12, Li Li, vice chairman and general manager of the company, increased his holding of a total of 300,000 shares in the company, accounting for 0.0055% of the company's total share capital; at the same time, it is planned to increase the number of shares in the company within 6 months from the announcement date is not less than 5 million shares, and the increase price is not higher than 50 yuan / share.

Hengtong shares: The controlling shareholder agrees to increase his holdings by 30 million yuan to 60 million yuan

Hengtong Shares (603223) announced on the evening of January 12 that Nanshan Investment, the company's controlling shareholder, Nanshan Group, increased its holding of 228,300 shares in the company on the same day, accounting for 0.08% of the company's total share capital. Nanshan Investment, a concerted actor of Nanshan Group, plans to increase its shareholding in the company at an appropriate price within three months from January 12, and the amount of shares to be increased is not less than 30 million yuan and not more than 60 million yuan (including the amount of shares that have been increased this time).

Longjin Pharmaceutical: Shareholder Lixing Industry intends to reduce its shareholding by no more than 6%.

Longjin Pharmaceutical (002750) announced on the evening of January 12 that shareholder Lixing Industrial Co., Ltd. plans to reduce its holding of no more than 24.03 million shares of the company (accounting for 6% of the company's total share capital) through centralized bidding, block trading or other legal means.

Chuanzhi Education: Shareholder Shanghai Chuangji intends to reduce its shareholding by no more than 2.7%.

Chuanzhi Education (003032) announced on the evening of January 12 that shareholder Shanghai Chuangji Investment Center (Limited Partnership) plans to reduce its holdings in the company by means of a centralized auction within six months after the 15 trading days from the date of the announcement and in a block transaction within six months after the date of the announcement disclosure, and within six months after the three trading days from the date of the announcement disclosure, a total of no more than 10.8651 million shares (accounting for 2.7% of the total share capital of the company).

JinkoTech: Bihua Venture Capital intends to reduce its stake by no more than 2%.

Jinko Technology (601778) announced on the evening of January 12 that Bihua Venture Capital, a shareholder holding 9.35% of the shares, intends to reduce its holdings by no more than 57.8829 million shares through centralized auction transactions within 6 months after 15 trading days, and the proportion of the reduction will not exceed 2% of the company's total share capital.

Shu Taishen: Shareholder Xiangtang Group intends to reduce its shareholding by no more than 2%.

Shu Taishen (300204) announced on the evening of January 12 that shareholder Xiangtang Group plans to reduce its holdings of the company's shares through centralized auction transactions on the stock exchange within 6 months after 15 trading days from the date of the announcement, that is, from February 10 to August 9, a total of no more than 9.4532 million shares, accounting for 2% of the company's total share capital with voting rights.

Yangtze River Health: Shareholder Zhongshan Songde intends to reduce its shareholding by no more than 2%.

Changjiang Health (002435) announced on the evening of January 12 that shareholder Zhongshan Songde Zhangjiagang Free Trade Zone Pharmaceutical Industry Equity Investment Enterprise (Limited Partnership) (hereinafter referred to as "Zhongshan Songde") plans to reduce its holding of no more than 24.71 million shares (accounting for 2% of the company's total share capital) within six months after 15 trading days from the date of the announcement by means of collective bidding and block trading.

Dingsheng New Material: Shareholder Lu Jinche intends to reduce his shareholding by no more than 1.17%.

Dingsheng New Material (603876) announced on the evening of January 12 that Lu Jinche, a shareholder holding 1.17% of the shares, plans to reduce his holdings by no more than 5.665 million shares through a centralized auction within 6 months after 15 trading days, and the proportion of the reduction will not exceed 1.17% of the company's total share capital.

【Winning Contract】

Zhejiang JiaotongKe: The consortium of subsidiaries intends to win the bid for a project of 2.366 billion yuan

Zhejiang Jiaoke (002061) announced on the evening of January 12 that the company's subsidiary Jiaogong Hongtu and China Highway Engineering Consulting Group Co., Ltd. formed a consortium to participate in the bidding of the SJSG section of the engineering design and construction of the engineering design and construction of the 351 National Highway Lanxi Majian to Jiande Daciyan section, and was the first winning candidate. The proposed bid amount is 2.366 billion yuan.

Guoxuan Hi-Tech: The subsidiary jointly won the bid for the 394 million yuan Huaibei Anhui Energy Storage Power Station project

Guoxuan Hi-Tech (002074) announced on the evening of January 12 that the consortium formed by hefei Guoxuan, a wholly-owned subsidiary, and the Southwest Electric Power Design Institute became the winning bidder of the "General Contracting of the First Phase of Huaibei Anhui Energy Storage Power Station (103MW/206MWh)", with a winning bid amount of 394 million yuan. The above-mentioned winning project will be implemented by the company's energy storage business sector, and the Huaibei Anhui Energy Storage Power Station will become the largest single capacity of the domestic grid-side lithium iron phosphate energy storage power station after all completion.

Weishitong: Signed a contract of 120 million yuan with Century Huatongsun Company

On the evening of January 12, Weishitong (002268) disclosed the progress of strategic cooperation with Century Huatong, and recently, Weishitong and Century Huatong Sun Company Sheng qu company signed the "Personal Information Security Compliance Service Project Entrusted Service Contract", Wei Shi Tong will provide personal information security compliance services for Sheng Qu Company, to ensure that Sheng Qu Company can establish and maintain a personal information security compliance system, the service period is three years, the total contract amount of 120 million yuan (including tax).

Shengxun shares: signed a procurement contract of 73.6 million yuan

Sound Xun Co., Ltd. (003004) announced on the evening of January 12 that recently, the company and Shenzhen ZTE System Integration Technology Co., Ltd. signed the "Beijing Rail Transit Line 3 Phase I Project Integrated Procurement Project Video Subsystem Procurement Contract", with a total contract amount of 73.6 million yuan, accounting for 23.9% of the company's audited operating income in 2020.

【Major Investment】

Oriental Shenghong: Plans to invest in the construction of ultra-simulated functional fiber projects and polyester filament projects

Oriental Shenghong (000301) announced on the evening of January 12 that Guowang Suqian, a wholly-owned subsidiary of the company's second-level subsidiary, will invest in the construction of the second phase of the 500,000 tons of super-simulated functional fiber project. The total investment of the project is expected to be 3.612 billion yuan, and the construction period is 2 years. Ruibang Technology, a wholly-owned subsidiary of the Company's second-level subsidiary, will invest in the construction of the second phase of the regeneration of differentiated and functional polyester filament and supporting elastic projects with an annual output of 250,000 tons. The total investment of the project is expected to be 2.838 billion yuan, and the construction period is 2 years.

Yongjin Shares: Plans to invest in the construction of an annual processing of 700,000 tons of wide-width cold-rolled stainless steel strip project

Yongjin Co., Ltd. (603995) announced on the evening of January 12 that the company intends to establish Yongjin Metal Technology (Indonesia) Co., Ltd. in Indonesia through its wholly-owned subsidiary Xinyue Assets and related party Qingzhan Industry to build a wide-width cold-rolled stainless steel strip project with an annual processing capacity of 700,000 tons. Among them, Xinyue Assets holds 60% of the equity of the project company, and Qingzhan Industry holds 40% of the equity. The total investment of the project is expected to be 2.133 billion yuan, of which the construction investment is 1.257 billion yuan, the planned construction period is 2 years, and the start time depends on the completion time of various procedures.

Fengyuan shares: the proposed increase in capital not more than 940 million yuan for lithium battery lithium iron phosphate cathode material production base project

Fengyuan Shares (002805) announced on the evening of January 12 that the total amount of funds raised by the company's proposed non-public offering will not exceed 940 million yuan, which will be used for the "annual output of 50,000 tons of lithium batteries lithium iron phosphate cathode material production base project" and "supplementary working capital project" after deducting the issuance fee. The targets of the non-public offering include Zhao Guanghui, the controlling shareholder, the actual controller and the chairman of the board of directors of the company.

Ewell Lithium Energy: Plans to invest in the construction of a power battery R&D center building project

Ewell Lithium Energy (300014) announced on the evening of January 12 that the company and its subsidiary Huizhou Ewell Power intend to invest in the construction of a power battery R&D center building project in Zhongkai High-tech Zone, of which the company invested 699 million yuan to build a "power battery R&D center" and build a new plant in The 71-2 plot of Chenjiang Street, Zhongkai High-tech Zone; Huizhou Ewell Power invested 236 million US dollars to build a "common technology research and development and innovation service platform for electrochemical energy storage and power battery industry".

Anxu Biologics: It is planned to use super-raised funds to invest in the construction of in vitro diagnostic reagents and diagnostic instrument research and development and production projects

Anxu Biotechnology (688075) announced on the evening of January 11 that with the outbreak of the new crown epidemic, the demand for reagents and testing instruments for instant detection in various countries around the world has greatly increased, especially the demand for foreign markets is huge. The company intends to invest in the construction of in vitro diagnostic reagents and diagnostic instrument research and development and production projects, implemented by its wholly-owned subsidiary Xumin Bio, with an estimated total investment of 508 million yuan. The total amount of the company's over-raised funds is 597 million yuan, and it intends to use part of the over-raised funds to invest in the project. After the completion of the project, it will further expand the company's production scale and improve the automation level of the production line.

Ashichuang: The subsidiary plans to invest 250 million yuan in the production of new materials such as vanadium alloys

A Shichuang (300706) announced on the evening of January 12 that the company's wholly-owned subsidiary Dingchuang Metal and the People's Government of Shaxian District of Sanming City recently signed a "Letter of Intent to Invest", and Dingchuang Metal intends to invest in the production of new materials such as vanadium alloys in Shaxian District of Sanming City. The project site is located in The Golden Paleont metal processing zone in Shaxian County. It plans to invest 250 million yuan, of which 150 million yuan will be invested in fixed assets. Mainly engaged in vanadium alloy and other new materials research and development, production and sales.

Li Ziyuan: The subsidiary plans to invest 200 million yuan to build 3 aseptic filling production lines for milk beverages

Liziyuan (605337) announced on the evening of January 12 that Yunnan Liziyuan Food Co., Ltd., a wholly-owned subsidiary of the company, plans to invest in the construction of 3 aseptic filling production lines for milk drinks, supporting the construction of warehouses and other ancillary facilities, with a total planned investment of about 200 million yuan.

【Others】

Beijing-Shanghai high-speed railway: Signed a strategic cooperation agreement with China Power

The Beijing-Shanghai High-Speed Railway (601816) announced on the evening of January 12 that the company signed a strategic cooperation agreement with China Electric Power on January 11 to carry out strong alliances in many fields such as power market-oriented trading, integrated smart energy investment, construction and operation, carbon trading, and green certificate green electricity trading.

Dongfeng Co., Ltd.: The subsidiary signed a strategic cooperation agreement with Bosheng New Materials

Dongfeng Co., Ltd. (601515) announced on the evening of January 12 that in order to promote the strategic implementation of the company's new energy materials sector and further optimize the company's industrial layout in the field of new membrane materials, the company's wholly-owned subsidiary Guangdong Xinrui New Material Technology Co., Ltd. and Shenzhen Bosheng New Materials Co., Ltd. jointly signed a "Strategic Cooperation Agreement", and the two sides intend to establish a multi-level, multi-level, A comprehensive long-term strategic partnership with win-win relationship.

Haowu Shares: Some 4S stores under the subsidiary have suspended operations due to the impact of the epidemic

Haowu Co., Ltd. (000757) announced on the evening of January 12 that 19 companies under the company's wholly-owned subsidiary Neijiang Pengxiang are located in Tianjin, of which 5 4S stores have suspended operations in accordance with the requirements of Tianjin's new crown epidemic prevention and control; the remaining 14 4S stores and 3 other subsidiaries have orderly controlled the flow of employees or worked from home according to the epidemic prevention and control requirements in order to fully cooperate with the epidemic prevention work. The specific time for resuming operations will be determined according to the progress of the overall epidemic prevention and control work in Tianjin. It is expected to have a certain adverse impact on the company's operating results in 2022.

Rongsheng Petrochemical: The subsidiary refining and chemical integration project (Phase II) was fully put into operation

Rongsheng Petrochemical (002493) announced on the evening of January 12 that the holding subsidiary Zhejiang Petrochemical 40 million tons / year refining and chemical integration project (Phase II) was fully put into operation. Up to now, the second phase of the project refining, aromatics, ethylene and downstream chemical devices have been fully put into testing, open up the whole process, the company will further improve the debugging of relevant process parameters, improve the level of production and operation.

Wan Bond: The subsidiary's medical surgical masks passed the US FDA 510(K) audit

Wanbond (002082) announced on the evening of January 12 that Wanbond Medical, a holding subsidiary of the company, received a notice from the US FDA that Wanbond Medical medical surgical masks officially passed the review of THE US FDA 510(K).

Renfu Medicine: The clinical trial of White Res Pill was approved

Renfu Pharmaceutical (600079) announced on the evening of January 12 that Bai Resi Pill, a joint research and development project cooperated by renfu R&D Center, a wholly-owned subsidiary of the company, and the Uygur Medical Research Institute of Xinjiang Uygur Autonomous Region, recently received the "Notice of Approval of Drug Clinical Trials" approved and issued by the State Food and Drug Administration. White-heat pills are intended for the treatment of stable vitiligo.

Yingke Medical: The controlling shareholder and actual controller promised not to reduce its holdings in the company's shares

Yingke Medical (300677) announced on the evening of January 12 that Liu Fangyi, the controlling shareholder and actual controller of the company, signed the "Commitment Letter on Not Reducing the Shares of Yingke Medical Technology Co., Ltd.", and Liu Fangyi voluntarily promised that from the date of the commitment letter to June 30, 2023, he would not reduce any shares of Yingke Medical held by him through centralized bidding, block trading and agreement transfer (including shares increased during the commitment period due to the issuance of shares by Yingke Medical, the conversion of capital reserves into increased share capital, etc.).

Guangyang Co., Ltd.: The company was designated as a supplier of BorgWarner dual clutch module separation bearing project

Guangyang Co., Ltd. (002708) announced on the evening of January 12 that the company recently received a "fixed-point letter" from BorgWarner, and the company was accused

It will be a production supplier for the double clutch module separation bearing project.

Hualan Biologics: The IPO of Hualan Vaccine CHINext, a holding subsidiary, was registered by the CSRC

Hualan Biotech (002007) announced on the evening of January 12 that according to the "Reply on Agreeing to the Registration of the Initial Public Offering of Shares of Hualan Biopharmaceutical Co., Ltd." issued by the China Securities Regulatory Commission on January 12, the CSRC agreed to the registration application of the holding subsidiary Hualan Vaccine for the initial public offering of shares on the Growth Enterprise Market.

Fuchun shares: The controlling shareholder and the actual controller are suspected of securities violations and have been filed by the CSRC

Fuchun Shares (300299) announced on the evening of January 12 that the company received a notice from the company's controlling shareholder, Fujian Fuchun Investment Co., Ltd., the actual controller Miao Pinzhang, and the president Chen Ping, that it had received the "Notice of Case Filing" from the China Securities Regulatory Commission, and because it was suspected of securities violations and violations, according to relevant laws and regulations, the China Securities Regulatory Commission decided to file a case against it. According to the company's preliminary understanding, the case filing is a special investigation into the relevant parties' large transactions at the end of 2020 or there are non-compliant situations, which do not involve the company's financial fraud, capital occupation, illegal guarantees, etc., have nothing to do with the listed company, and will not affect the daily business activities of the company and its subsidiaries.

TISCO Stainless Steel: The directors of the company received a notice of filing a case from the CSRC

TISCO Stainless Steel (000825) announced on the evening of January 12 that the company received a notice from director Chai Zhiyong on January 11, and Chai Zhiyong received a "Notice of Case Filing" from the China Securities Regulatory Commission on January 10, because it was suspected of leaking insider information, and according to the Securities Law of the People's Republic of China, the Administrative Punishment Law of the People's Republic of China and other laws and regulations, the China Securities Regulatory Commission decided to file a case against him. The above matters only involve Chai Zhiyong personally, and the company's production and operation activities are normal.

Read on